Invention Grant
- Patent Title: Azabenzimidazole derivative having AMPK-activating activity
- Patent Title (中): 具有AMPK活化活性的偶氮苯并咪唑衍生物
-
Application No.: US14233058Application Date: 2012-07-13
-
Publication No.: US09567330B2Publication Date: 2017-02-14
- Inventor: Eiichi Kojima , Keisuke Tonogaki , Nobuyuki Tanaka , Manabu Katou , Akira Ino , Masafumi Iwatsu , Masahiko Fujioka , Yu Hinata , Naoki Ohyabu
- Applicant: Eiichi Kojima , Keisuke Tonogaki , Nobuyuki Tanaka , Manabu Katou , Akira Ino , Masafumi Iwatsu , Masahiko Fujioka , Yu Hinata , Naoki Ohyabu
- Applicant Address: JP Osaka-shi
- Assignee: Shionogi & Co., Ltd.
- Current Assignee: Shionogi & Co., Ltd.
- Current Assignee Address: JP Osaka-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2011-156297 20110715; JP2012-055785 20120313
- International Application: PCT/JP2012/067889 WO 20120713
- International Announcement: WO2013/011932 WO 20130124
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; C07F9/6561 ; C07D451/06

Abstract:
Disclosed is a compound which is useful as an AMPK activator.A compound represented by formula: or a pharmaceutically acceptable salt thereof, wherein R4 is hydrogen, or substituted or unsubstituted alkyl, R1, R2 and R3 are each independently hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl or the like, with the proviso that R1, R2 and R3 are not simultaneously hydrogen, X is a single bond, —S—, —O—, —NR5—, —C(═O)— or the like, R5 is hydrogen, or substituted or unsubstituted alkyl, Y is substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted heterocyclyl or the like.
Public/Granted literature
- US20140194420A1 AZABENZIMIDAZOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY Public/Granted day:2014-07-10
Information query